Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advanced Diagnostics 2016

Chamindie Punyadeera's Biography



Chamindie Punyadeera, Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology

Associate Professor Chamindie Punyadeera is an entrepreneur with a track record in innovation, industry engagement, intellectual property generation, and business development. She is a globally acknowledged pioneer in salivary diagnostics. She obtained her Ph.D. in Clinical Chemistry from the University of Witwatersrand, South Africa, prior to undertaking postdoctoral training with Professor Ton de Goeij, at the University of Masstricht, The Netherlands. She subsequently joined Royal Philips Electronics, Eindhoven, The Netherlands, as a Senior Scientist/Project Leader. Currently she heads the Saliva Translational Research (STaR) laboratory at the Queensland University of Technology, Australia. Her team focuses on developing novel diagnostic and prognostic biomarkers for cardiovascular diseases, head and neck cancers and linking oral health to systemic diseases. She has collaborative projects with Johnson & Johnson, MDx-health, Mawi-DNA Technologies and Oasis Diagnostics, is a consultant to Oasis Diagnostics® and FLUIDS iQ™. She has 13 PCT patents and over 60 refereed publications, including 4 invited book chapters, and serves on the Editorial Board of the Journal of Oral Oncology and the Associate Editor to the Journal of Dento Medical Science.

Chamindie Punyadeera Image

The Development of Salivary Biomarkers to Detect Systemic Diseases

Thursday, 26 May 2016 at 11:15

Add to Calendar ▼2016-05-26 11:15:002016-05-26 12:15:00Europe/LondonThe Development of Salivary Biomarkers to Detect Systemic DiseasesAdvanced Diagnostics 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

In this presentation, the speaker will discuss the technology developed for quantifying CRP levels in saliva samples and its use as a biological matrix to detect ischemic heart disease and heart failure. The talk will also mention how by analysis of salivary DNA methylation and miRNA signatures along with identification of tumour suppressor genes, cancers like head and neck cancer, especially oral cavity cancers can be detected. Further, it will discuss about role of (MSP) assay and panel of nine miRNA markers in determining specific methylation events. Finally, it will highlight how saliva is an ideal biological medium to detect both oral and systemic events along with future prospects.


Add to Calendar ▼2016-05-26 00:00:002016-05-27 00:00:00Europe/LondonAdvanced Diagnostics 2016Advanced Diagnostics 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com